Capro Corp. | Mutual Funds
Mutual Funds that own Capro Corp.
DFA Emerging Markets Small Cap Series
332,967
0.83%
0
0.03%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
317,977
0.8%
0
0.01%
04/30/2018
DFA Dimensional Emerging Markets Value Fund
87,634
0.22%
0
0%
01/31/2018
Mirae Asset TIGER Chemicals ETF
30,753
0.08%
21,842
0.9%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
18,570
0.05%
0
0.01%
12/31/2017
DFA TA World (ex-US) Core Equity Portfolio
15,677
0.04%
0
0%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
10,522
0.03%
-3,610
0%
04/30/2018
9,596
0.02%
6,188
0.03%
04/30/2018
John Hancock II - Emerging Markets Fund
9,263
0.02%
4,755
0.01%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
7,986
0.02%
-2,784
0%
04/30/2018
| Address |
14/F, Neewei Building
Seoul SL 04539
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.hcccapro.co.kr |
| Updated |
07/08/2019 |
| Capro Corp. engages in the manufacture and sale of caprolactam and ammonium sulfate. Its products include Caprolactam, ammonlum sulphate, ammonlum sulphate nitrate, and methylethylketoxime. The company was founded on December 30, 1969 and is headquartered in Seoul, South Korea. |
